ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALEX GOLDSMITH M.D.

Endocrinology, Diabetes Metabolism

8,088

$532K

498
444 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 48%

$66
Average prescription price

Avg: $125

JAMES SPEED M.D.

Endocrinology, Diabetes Metabolism

7,421

$1.32M

584
362 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 48%

$178
Average prescription price

Avg: $125

DANIEL CITRON M.D.

Endocrinology, Diabetes Metabolism

5,437

$318K

364
325 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 48%

$58
Average prescription price

Avg: $125

JOSEPH MARUCA MD

Endocrinology, Diabetes Metabolism

4,285

$394K

343
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 48%

$92
Average prescription price

Avg: $125

LEONARD ZEMEL M.D.

Endocrinology, Diabetes Metabolism

4,142

$362K

328
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 48%

$87
Average prescription price

Avg: $125

DAVID PODLECKI MD

Endocrinology, Diabetes Metabolism

3,249

$438K

238
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$135
Average prescription price

Avg: $125

CHRISTOPHER RICCA M.D.

Endocrinology, Diabetes Metabolism

3,107

$263K

111
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 48%

$85
Average prescription price

Avg: $125

HANAH POLOTSKY MD

Endocrinology, Diabetes Metabolism

3,041

$152K

482
385 are 65+

15%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 48%

$50
Average prescription price

Avg: $125

MERVYN LIFSCHITZ M.D.

Endocrinology, Diabetes Metabolism

2,876

$171K

247
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 48%

$60
Average prescription price

Avg: $125

MERIAM IZON M.D.

Endocrinology, Diabetes Metabolism

2,783

$363K

262
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 48%

$130
Average prescription price

Avg: $125

KEVIN TONG MD

Endocrinology, Diabetes Metabolism

2,742

$278K

219
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 48%

$101
Average prescription price

Avg: $125

MELVIN STJERNHOLM M.D.

Endocrinology, Diabetes Metabolism

2,404

$265K

183
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$110
Average prescription price

Avg: $125

IRINA ROBINSON M.D.

Endocrinology, Diabetes Metabolism

2,389

$300K

220
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 48%

$126
Average prescription price

Avg: $125

MICHAEL MCDERMOTT MD

Endocrinology, Diabetes Metabolism

2,328

$459K

213
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 48%

$197
Average prescription price

Avg: $125

BARBARA WIDOM M.D.

Endocrinology, Diabetes Metabolism

2,324

$325K

201
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 48%

$140
Average prescription price

Avg: $125

GREGORY HUGHES MD

Endocrinology, Diabetes Metabolism

2,082

$462K

228
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 48%

$222
Average prescription price

Avg: $125

MARGARET EAGAN MD

Endocrinology, Diabetes Metabolism

2,060

$174K

176
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 48%

$84
Average prescription price

Avg: $125

MICHELLE CASSARA MD

Endocrinology, Diabetes Metabolism

2,015

$358K

239
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 48%

$178
Average prescription price

Avg: $125

VINAYA KAMATH M.D.

Endocrinology, Diabetes Metabolism

1,987

$257K

182
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 48%

$129
Average prescription price

Avg: $125

DAVID DEPAOLO MD

Endocrinology, Diabetes Metabolism

1,895

$214K

322
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 48%

$113
Average prescription price

Avg: $125

SUSAN SHERMAN MD

Endocrinology, Diabetes Metabolism

1,796

$275K

236
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 48%

$153
Average prescription price

Avg: $125

JULIE TALAVERA M.D.

Endocrinology, Diabetes Metabolism

1,778

$182K

174
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 48%

$102
Average prescription price

Avg: $125

KENNETH DERNOVSEK MD

Endocrinology, Diabetes Metabolism

1,730

$309K

239
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 48%

$178
Average prescription price

Avg: $125

ROMANA HAAS MD

Endocrinology, Diabetes Metabolism

1,685

$313K

142
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 48%

$186
Average prescription price

Avg: $125

JULIA RIFKIN MD

Endocrinology, Diabetes Metabolism

1,567

$87.2K

192
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 48%

$56
Average prescription price

Avg: $125

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank